Versartis Closes $20 Million Series D Venture Financing New Capital Will Support Preparations for Phase 3 Trial of Long-Acting Human Growth Hormone in Pediatric Patients Redwood City, CA – October 8, 2013 – Versartis, Inc., an emerging biotechnology company developing...
Spiracur and Century Medical Announce Multiple SNaP System Sales in Japan After Ministry of Health, Labor and Welfare Grants Reimbursement Proven Advanced Wound Care Device Offers Patients in Japan Effective, Non-powered Treatment for Chronic, Acute Wounds; Improves...
CardioKinetix Announces First Heart Failure Patients Treated in China with Novel Minimally Invasive Structural Heart Device Menlo Park, Calif. – October 14, 2013 – CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart...
Relypsa Reports Positive Topline Results for its 52-Week Phase 2b Trial of Patiromer Redwood City, CA, October 17, 2013 – Relypsa, Inc., a clinical-stage biopharmaceutical company, today announced that its Phase 2b trial studying the safety and efficacy of patiromer...
Advanced Cell Diagnostics and Kindstar Global Announce Partnership to Launch Cancer Diagnostic Tests in China HAYWARD, CA & WUHAN, CHINA, Oct. 23, 2013—Advanced Cell Diagnostics, Inc. (ACD) and Kindstar Global (Kindstar) today announced that Kindstar will begin...
Recent Comments